| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3390/IJMS17081266 |
| P8608 | Fatcat ID | release_xb64n5cnvvddrmv4khqxmzg2xe |
| P3181 | OpenCitations bibliographic resource ID | 4125520 |
| P932 | PMC publication ID | 5000664 |
| P698 | PubMed publication ID | 27527155 |
| P50 | author | Giulia Gallerani | Q57079237 |
| Francesco Fabbri | Q39596195 | ||
| P2093 | author name string | Francesco Fabbri | |
| Giulia Gallerani | |||
| P2860 | cites work | Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity | Q24297858 |
| Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis | Q24602426 | ||
| Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression | Q24633875 | ||
| Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance | Q26744341 | ||
| Continuing climb in rates of esophageal adenocarcinoma: an update | Q72902169 | ||
| Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans | Q73137206 | ||
| Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis | Q80403402 | ||
| Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers | Q81920744 | ||
| Esophageal carcinoma | Q86401144 | ||
| The epidemic of oesophageal carcinoma: Where are we now? | Q87241077 | ||
| Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis | Q26786469 | ||
| Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research | Q27024191 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| The genomic landscapes of human breast and colorectal cancers | Q27861078 | ||
| Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4 | Q28534173 | ||
| Tumour evolution inferred by single-cell sequencing | Q28646966 | ||
| Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition | Q29615853 | ||
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer | Q29619276 | ||
| Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer | Q30080026 | ||
| Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data | Q30779447 | ||
| The changing epidemiology of esophageal cancer | Q33776309 | ||
| Circulating tumor cells predict survival in early average-to-high risk breast cancer patients | Q33958981 | ||
| Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis | Q34111187 | ||
| Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation | Q34238141 | ||
| Oesophageal carcinoma | Q34325751 | ||
| Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer | Q34344437 | ||
| Genetic clonal diversity predicts progression to esophageal adenocarcinoma | Q34505745 | ||
| Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus | Q34547790 | ||
| How cells change their phenotype | Q34627229 | ||
| Biology of Barrett's esophagus and esophageal adenocarcinoma | Q34644324 | ||
| Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus | Q34761782 | ||
| Transitions between epithelial and mesenchymal states in development and disease | Q34761972 | ||
| Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer | Q34790678 | ||
| Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. | Q35613515 | ||
| A microfluidic device for label-free, physical capture of circulating tumor cell clusters | Q35812039 | ||
| Imaging of esophageal and gastric cancer | Q35857442 | ||
| Paired exome analysis of Barrett's esophagus and adenocarcinoma | Q36004465 | ||
| The fallacy of epithelial mesenchymal transition in neoplasia | Q36197878 | ||
| Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis | Q36205151 | ||
| Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma | Q36322862 | ||
| The isolation and characterization of CTC subsets related to breast cancer dormancy | Q36343283 | ||
| Circulating tumor cells: the 'leukemic phase' of solid cancers | Q36400649 | ||
| A single progenitor population switches behavior to maintain and repair esophageal epithelium | Q36479797 | ||
| Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study | Q36783294 | ||
| Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. | Q53479490 | ||
| Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction. | Q54689577 | ||
| Esophageal Cancer | Q56209683 | ||
| Circulating tumor cells in early breast cancer: A connection with vascular invasion | Q56968102 | ||
| Barrett's metaplasia | Q58105006 | ||
| Cancer theory faces doubts | Q59053954 | ||
| Role of Positron Emission Tomography in Staging Esophageal Cancer | Q61889951 | ||
| Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity | Q36918993 | ||
| The identification and characterization of breast cancer CTCs competent for brain metastasis | Q37394096 | ||
| Next-generation sequencing of disseminated tumor cells | Q37421423 | ||
| 18F-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer: systematic review of the literature | Q37564960 | ||
| Utilizing circulating tumor cells: challenges and pitfalls | Q37812976 | ||
| Barrett's esophagus: treatment or observation of a major precursor factor of esophageal cancer? | Q37946811 | ||
| Epidemiologic risk factors for esophageal cancer development | Q37982813 | ||
| Barrett's Esophagus: A Review of Biology and Therapeutic Approaches. | Q38018063 | ||
| The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer | Q38113419 | ||
| The '-omics' revolution and oesophageal adenocarcinoma | Q38132057 | ||
| Real-time liquid biopsy in cancer patients: fact or fiction? | Q38154437 | ||
| Epithelial plasticity: a common theme in embryonic and cancer cells. | Q38160727 | ||
| Tumor metastasis: moving new biological insights into the clinic | Q38160740 | ||
| Molecular analysis of circulating tumour cells-biology and biomarkers | Q38180320 | ||
| The role of inflammation in cancer of the esophagus | Q38214324 | ||
| Biology, detection, and clinical implications of circulating tumor cells | Q38268371 | ||
| Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations. | Q38285674 | ||
| Inflammation fuels tumor progress and metastasis | Q38500455 | ||
| The biology of circulating tumor cells | Q38518846 | ||
| Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation | Q38741742 | ||
| Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. | Q38771051 | ||
| Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing | Q38778349 | ||
| CTCs in early breast cancer: A path worth taking. | Q38802633 | ||
| Context-dependent adaption of EpCAM expression in early systemic esophageal cancer | Q39076253 | ||
| Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. | Q39192398 | ||
| Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced Gastric and Gastroesophageal Adenocarcinomas | Q40599089 | ||
| Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer | Q41225190 | ||
| Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer. | Q41549412 | ||
| Development. Esophageal stem cells, where art thou? | Q42584384 | ||
| Challenges in circulating tumour cell research | Q43500645 | ||
| Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. | Q44298526 | ||
| Population attributable risks of esophageal and gastric cancers | Q44586583 | ||
| Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing | Q46302330 | ||
| A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers. | Q46624302 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| circulating tumor cell | Q5121689 | ||
| esophageal neoplasm | Q56014520 | ||
| tumor biomarker | Q66205818 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P577 | publication date | 2016-08-04 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Circulating Tumor Cells in the Adenocarcinoma of the Esophagus | |
| P478 | volume | 17 |
| Q92960474 | CTCs 2020: Great Expectations or Unreasonable Dreams |
| Q38765748 | Circulating Tumor Cells: Back to the Future |
| Q91194970 | Highlighting the uniqueness in dielectrophoretic enrichment of circulating tumor cells |
| Q42378538 | Predictive Value of Circulating Tumor Cells for Evaluating Short- and Long-Term Efficacy of Chemotherapy for Breast Cancer. |
Search more.